Previous studies have shown that DNA-damaging in vivo chemotherapy of AML has no effect on MCL-1 gene induction, but rapidly induces BAX and PUMA mRNA [3] (Øyan et al., manuscript in preparation). Here, MCL1 is linked to acute myeloid leukemia.